Epizyme (EPZM) Revised Celgene Agreement 'Net Positive', Mizuho Securities Says

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/26/2026

1. INTU
2. DKS
3. ZM
4. SMTC
5. META
6. SPY
7. NCNO
8. JAZZ
9. BOX
10. NVDA

Go back to Epizyme (EPZM) Revised Celgene Agreement 'Net Positive', Mizuho Securities Says

Extension of Celgene (CELG) Collaboration Highlights Partner Interest in Epizyme (EPZM) - Leerink

July 10, 2015 8:49 AM EDT

Leerink affirmed Epizyme (Nasdaq: EPZM) at Outperform with a price target of $48 following new collaboration news issued Thursday.

Analyst Howard Liang, Ph.D, commented, We believe the extension of the research collaboration with Celgene (Nasdaq:... More